Future prospects of population-based mammographic screening

Seminars in Surgical Oncology

Volumn 12, Issue 1, 1996, Pages 26-31

  Holmberg, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cost effectiveness; false negative results; mammography; program efficiency; psychological effects

Indexed keywords

BREAST CANCER; CANCER SCREENING; CLINICAL RESEARCH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; MAMMOGRAPHY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FORECASTING; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; RESEARCH;

EID: 0030059304     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199601/02)12:1<26::AID-SSU4>3.0.CO;2-8     Document Type: Review

References (36)

1. Shapiro S, Venet W, Strax P, et al: Selection, follow-up, and analysis in the Health Insurance Plan study: A randomized trial with breast cancer screening. Natl Cancer Inst Monogr 67:65-74, 1985.
2. Tabàr L, Gad A: Screening for breast cancer: the Swedish trial Radiology 138:219-222, 1981.
3. Tabàr L, Fagerberg CJ, Gad A, et al: Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1:829-32, 1985.
4. Verbeek ALM, Hendriks JHCL, Holland R, et al: Reduction of breast cancer mortality through mass screening with modern mammography: First results of the Nijmegen Project, 1975-1981. Lancet 1:1222-224, 1984.
5. Collette HJ, Day NE, Rombach JJ, et al: Evaluation of screening for breast cancer in a non randomised study (the DOM project) by means of a case control study. Lancet 1:1224-1226, 1984.
6. Hurley SF, Kaldor JM: The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 14:101-130, 1992.
7. Kerlikowske K, Grady D, Rubin SM, et al: Efficacy of screening mammography. A meta-analysis. JAMA 273:149-154, 1995.
8. Nyström L, Rutquist LE, Wall S, et al: Breast cancer screening with mammography: Overview of Swedish randomized trials. Lancet 341:973-978, 1993.
9. Day NE, Williams DRR, Khaw KT: Breast cancer screening programmes: The development of a monitoring and evaluation system. Br J Cancer 59:954-958, 1989.
10. Holmberg L: Evaluation of breast-cancer screening programs. Cancer 72(suppl):1433-1436, 1993.
11. Swanson GM: May we agree to disagree, or how do we develop guidelines for breast cancer screening in women? J Natl Cancer Inst 86.903-905, 1994.
12. Elwood JM, Cox B, Richardson AK: The effectiveness of breast cancer screening in young women. Online J Curr Clin Trials doc No 32. 930225, 1993.
13. Kopans DB: The controversy of mammography screening. Admin Radiol 15:13-24, 1995.
14. Thomas BA: Commentary. Population breast cancer screening: theory practice, and service implications. Lancet 345:205-207, 1995.
15. Viewpoint: the future. Through the glass lightly. (A collection of scientists interviewed.) Science 267:1609-1618, 1995.
16. Eckhardt S, Badellino F, Murphy GP: UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Int J Cancer 56:1-5, 1994.
17. Koning HJ de, Ineveld BM van, Oortmarssen GJ van, et al: Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49:531-537, 1991.
18. Dijck JAAM van, Holland R, Verbeek ALM, et al: Efficacy of mammography screening in the elderly: A case-referent study in the Nijmegen program in the Netherlands. J Natl Cancer Inst 86:934-938, 1994.
19. Tabàr L, Fagerberg G, Day NE, Holmberg L: What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55:547-551, 1987.
20. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P: Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 310:224-226, 1995.
21. Hakama M, Elovainio L, Kajantie R, et al: Breast cancer screening as public health policy in Finland. Br J Cancer 64:962-964, 1991.
22. Ineveld BM van, Oortmarssen GJ van, Koning HJ de, Boer R, Maas PJ van der: How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 29A:1663-1668, 1993.
23. Beemsterboer PMM, Kenning HJ de, Warmerdam PG, et al: Prediction of the effects and costs of breast cancer screening in Germany. Int J Cancer 58:623-628, 1994.
24. Koning HJ de, Oortmarssen GJ van, Ineveld BM van, Maas PJ van der: Breast cancer screening: Its impact on clinical medicine. Br J Cancer 61:292-297, 1990.
25. Holmberg L, Adami HO, Persson I, et al: Demands on surgical inpatient services after mass mammographic screening. Br Med J 293:779-782, 1986.
26. Beahrs OH, Shapiro S, Smart C, et al: Summary report of the working group to review the National Cancer Institute-American Cancer Society Breast Cancer Demonstration Projects. J Natl Cancer Inst 62:641-693, 1979.
27. Lee-Feldstein A, Anton-Culver H, Feldstein PJ: Treatment differences and other prognostic factors related to breast cancer survival. JAMA 271:1163-1168, 1994.
28. Dean C, Roberts MM, French K, Robinson S: Psychiatric morbidity after screening for breast cancer. J Epidemiol Community Health 40:71-75, 1986.
29. Ellman R, Angeli N, Christians S, et al: Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 60:781-784, 1989.
30. Gram IT, Slenker SE: Cancer anxiety and attitudes toward mammography among screening attenders, non-attenders and women never invited. Am J Public Health 82:249-251, 1992.
31. Cockburn J, Staples M. Hurley SF, De Luise T: Psychological consequences of screening mammography. J Med Screening 1:7-12, 1994.
32. Holmberg L, Tabàr L, Adami HO, Bergstrom R: Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 2:27-30, 1986.
33. Frisell J, Eklund G, Hellstrom L, Somell A: Analysis of interval breast carcinomas in a randomised screening trial in Stockholm. Breast Cancer Res Treat 9:219-225, 1987.
34. Peeters PHM, Verbeek ALM, Hendriks JHCL, et al: The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59:929-933, 1989.
35. Andersson I, Aspegren K, Janzon L, et al: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 297:943-948, 1988.
36. Popper KR: The myth of the framework. In: Notterno MA (ed): "The Myth of the Framework." London: Routledge, 1994, 33-65.